Stage III Ureter Cancer AJCC v7
specificStage II includes: T2, N0, M0. T2: Tumor invades the muscularis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)
60
Centers
58
Active Trials
—
Cancer Funding
Top Centers for Stage III Ureter Cancer AJCC v7(60)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 51.6 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 51.6 |
| 3 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 51.6 |
| 4 | NCI Comprehensive Active Research Program | 51.6 |
| 5 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 51.6 |
| 6 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 51.6 |
| 7 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 51.6 |
| 8 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 51.6 |
| 9 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 51.6 |
| 10 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 51.6 |
| 11 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 51.6 |
| 12 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 51.6 |
| 13 | NCI Comprehensive Active Research Program | 51.6 |
| 14 | NCI Comprehensive Active Research Program | 51.6 |
| 15 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 51.6 |
| 16 | NCI Comprehensive Active Research Program | 51.6 |
| 17 | NCI Comprehensive Active Research Program | 51.6 |
| 18 | NCI Comprehensive Active Research Program | 51.6 |
| 19 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 51.6 |
| 20 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 51.6 |
| 21 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 51.6 |
| 22 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 51.6 |
| 23 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 51.6 |
| 24 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 51.6 |
| 25 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 51.6 |
| 26 | NCI Comprehensive Active Research Program | 51.6 |
| 27 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 51.6 |
| 28 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 51.6 |
| 29 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 51.6 |
| 30 | NCI Clinical Active Research Program | 51.6 |
| 31 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 51.6 |
| 32 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 51.6 |
| 33 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 51.6 |
| 34 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 51.6 |
| 35 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program | 51.6 |
| 36 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 51.6 |
| 37 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program | 51.6 |
| 38 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 51.6 |
| 39 | University of Illinois Cancer CenterChicago, IL Active Research Program | 51.6 |
| 40 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 51.6 |
| 41 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 51.6 |
| 42 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 51.6 |
| 43 | Boston University Cancer CenterBoston, MA Active Research Program | 51.6 |
| 44 | Active Research Program | 51.6 |
| 45 | Cancer Center at IllinoisUrbana, IL Active Research Program | 51.6 |
| 46 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 51.6 |
| 47 | The Jackson Laboratory Cancer CenterBar Harbor, ME NCI Basic_laboratory Active Research Program | 51.6 |
| 48 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 51.6 |
| 49 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 51.6 |
| 50 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 51.6 |
| 51 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 51.6 |
| 52 | Ellis Fischel Cancer Center, MU Health CareColumbia, MO Active Research Program | 51.6 |
| 53 | The University of Vermont Cancer CenterBurlington, VT Active Research Program | 51.6 |
| 54 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 51.6 |
| 55 | Upstate Cancer CenterSyracuse, NY Active Research Program | 51.6 |
| 56 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 51.6 |
| 57 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 51.6 |
| 58 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 51.6 |
| 59 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 29.1 |
| 60 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 29.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →